RAB40C
Basic information
Region (hg38): 16:589357-629272
Previous symbols: [ "RASL8C" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAB40C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 2 | 1 |
Variants in RAB40C
This is a list of pathogenic ClinVar variants found in the RAB40C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-590302-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
16-625438-C-A | not specified | Uncertain significance (Nov 17, 2022) | ||
16-625985-G-A | Benign (Jan 19, 2018) | |||
16-626043-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
16-626057-C-A | not specified | Uncertain significance (Nov 26, 2024) | ||
16-626073-A-G | not specified | Uncertain significance (Feb 15, 2023) | ||
16-626079-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
16-627342-T-C | not specified | Uncertain significance (Dec 06, 2021) | ||
16-627369-G-A | not specified | Uncertain significance (Nov 25, 2024) | ||
16-627464-G-A | not specified | Uncertain significance (May 20, 2024) | ||
16-627509-A-T | not specified | Uncertain significance (Aug 28, 2023) | ||
16-627524-G-A | not specified | Likely benign (Feb 06, 2023) | ||
16-627579-G-T | not specified | Uncertain significance (Dec 17, 2021) | ||
16-627581-C-T | not specified | Uncertain significance (Aug 11, 2022) | ||
16-627587-C-A | not specified | Uncertain significance (Feb 21, 2024) | ||
16-627598-G-T | Likely benign (Apr 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RAB40C | protein_coding | protein_coding | ENST00000535977 | 6 | 39916 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0154 | 0.961 | 125647 | 0 | 5 | 125652 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.34 | 110 | 204 | 0.539 | 0.0000143 | 1840 |
Missense in Polyphen | 57 | 107.36 | 0.5309 | 1030 | ||
Synonymous | -1.03 | 101 | 88.6 | 1.14 | 0.00000668 | 551 |
Loss of Function | 1.97 | 5 | 12.5 | 0.399 | 6.20e-7 | 134 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000481 | 0.0000462 |
European (Non-Finnish) | 0.0000267 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000269|PubMed:15601820}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;RAB geranylgeranylation
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.353
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.31
Haploinsufficiency Scores
- pHI
- 0.140
- hipred
- Y
- hipred_score
- 0.528
- ghis
- 0.642
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.754
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rab40c
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- intracellular protein transport;protein ubiquitination;Rab protein signal transduction
- Cellular component
- Golgi membrane;plasma membrane;perinuclear region of cytoplasm
- Molecular function
- GTPase activity;GTP binding;GDP binding